Results 61 to 70 of about 1,206 (142)
Andreas M Pleil,1 Feyza Darendeliler,2 Helmuth G Dörr,3 Katherine Hutchinson,4 Hartmut A Wollmann5 1Pfizer Inc., San Diego, CA, USA; 2Istanbul Faculty of Medicine, Pediatric Endocrinology Unit, Capa, Istanbul, Turkey; 3Department of Pediatrics ...
Pleil AM +4 more
doaj
Paolo Beck-Peccoz,1 Charlotte Höybye,2 Suat Simsek,3 Günter Stalla,4 Robert D Murray,5 Altaher Esmael,6 Dragan Urosevic,7 Anca Boldea,6 Markus Zabransky6 1Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore ...
Beck-Peccoz P +8 more
doaj
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
J Paul Frindik1, Stephen F Kemp11University of Arkansas for Medical Sciences and Arkansas Children’s Hospital, AR, USAAbstract: Idiopathic short stature (ISS) is a term that describes short stature in children who do not have growth hormone (GH)
J Paul Frindik, Stephen F Kemp
doaj
Helen A Spoudeas,1 Priti Bajaj,2 Nathan Sommerford3 1London Centre for Paediatric Endocrinology, University College London, London, 2Ferring Pharmaceuticals, London, 3Health Informatics Research, Sciensus Ltd, Brighton, UK Purpose: Persistence and ...
Spoudeas HA, Bajaj P, Sommerford N
doaj
Frequency of the use of anabolic drugs in bodybuilding athletes in Jahrom city
Introduction: Bodybuilding exercise is one of the most popular sports among the youth. Body builders use anabolic agents to increase their muscle growth and improve their appearance but the adverse effects of these drugs are greater than their advantages.
Saeed Sobhanian +3 more
doaj +2 more sources
Reports on long-term safety and effectiveness of daily GH replacement therapy in Japanese children with short stature due to Noonan syndrome (NS) are limited.
Koji Muroya +6 more
doaj +1 more source
Serious hematological adverse drug reactions (HADRs) may lead to or prolong hospitalization and even cause death. The aim of this study was to determine the regulatory factors associated with HADRs caused by drugs that were authorized up to July 2023 by ...
Ivana Stević +4 more
doaj +1 more source
Switching to Biosimilars in Inflammatory Rheumatic Conditions: Current Knowledge
Biosimilars are more affordable versions of previously approved biopharmaceuticals that are designed to reduce healthcare expenditure and increase patient access to this therapeutic class. To achieve their economic potential, many European countries have
Filipe C. Araújo +2 more
doaj
The efficacy and safety of weekly somatrogon treatment in turkish children with growth hormone deficiency: a real-world cohort study. [PDF]
Gider T +4 more
europepmc +1 more source
Physicochemical Differences Observed in Photostability Studies of Lyophilized, Reconstituted, and Diluted Somatropin. [PDF]
Pritts JD, Ortega-Rodriguez U, Rao VA.
europepmc +1 more source

